Serum HE4 levels are less frequently elevated than CA125 in women with benign gynecologic disorders

INTRODUCTION: HE4 is a novel biomarker for ovarian cancer. This study measured HE4 and CA125 levels in women with benign gynecologic disorders. METHODS: Sera were obtained from women prior to surgery for a pelvic mass and HE4 and CA125 levels were determined. The proportions of patients with elevate...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Moore, Richard G., Miller, M. Craig, Steinhoff, Margaret M., Skates, Steven J., Lu, Karen H., Lambert-Messerlian, Geralyn, Bast, Robert C.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2011
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3985608/
https://ncbi.nlm.nih.gov/pubmed/22284961
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajog.2011.12.029
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi